Zhengzheng Yu

CT-Derived Body Composition and Early Changes Predict Outcomes of First-Line Chemo-Immunotherapy in Recurrent/Metastatic Nasopharyngeal Carcinoma

Abstract Background Reliable biomarkers for risk stratification and treatment monitoring in recurrent/metastatic nasopharyngeal carcinoma (R/M NPC) treated with first-line chemo-immunotherapy remain limited. This study evaluated the prognostic value of baseline computed tomograph...